Source: Health Products Regulatory Authority (IE) Revision Year: 2018 Publisher: Amdipharm Limited,Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
Valoid 50 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, biconvex, uncoated tablet, scored; coded T4A. The scoreline is to facilitate breaking for ease of swallowing and to divide into equal doses. |
Each tablet contains 50mg of cyclizine hydrochloride.
Excipient with known effect: Lactose (60mg/tablet).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cyclizine |
Cyclizine is a histamine H1 receptor antagonist of the piperazine class which is characterised by a low incidence of drowsiness. It possesses anticholinergic and antiemetic properties. The exact mechanism by which cyclizine can prevent or suppress both nausea and vomiting from various causes is unknown. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Amber glass or polyethylene bottles with polyethylene tamper-evident caps for pack size 100 tablets.
Not all pack sizes may be marketed.
Amdipharm Limited,Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
PA1142/001/002
Date of first authorisation: 01 April 1979
Date of last renewal: 01 April 2009
| Drug | Countries | |
|---|---|---|
| VALOID | Ireland, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
